July 12, 2018
In Japan, young women and girls suffering from severe chronic generalized pain following vaccination with Merck’s Gardasil® or GSK’s Cervarix®, have organized and are speaking out.
The issues are being debated at public hearings, at which scientific presentations have been made by independent medical experts who validated the women’s suffering with documented evidence of the severe nature of the pain related to the HPV vaccine.
The opposing view, presented by scientists aligned with the vaccine establishment, disregarded the scientific plausibility of the evidence and declared the pain was a “psychosomatic reaction.”
Such public debates do not take place where vaccine stakeholders are in full control of vaccine safety information. (Like in the U.S., for example.)
Following a public hearing (February 2014), at which scientific evidence was presented by independent scientists , the Japanese government, not only rescinded its recommendation that girls receive the HPV vaccine, but established guidelines and special clinics for evaluating and treating illnesses caused by the vaccine.
It is a scenario that Merck, GSK, and vaccine stakeholders globally are extremely anxious to suppress.
The Merck-commissioned, CSIS report, co-authored by Dr. Larson, paints a picture of an all-out war over media coverage – not over the high rate of serious adverse reactions.
The authors resort to the usual tactic of discrediting vaccine-injured individuals; they dismissed the serious health effects suffered by girls and young women following vaccination, as trivial.
The CSIS report presents the entire issue as an epidemic fueled by Internet rumors and “vaccine hesitators.”
Over the last year, controversy within the Japanese medical and political arenas over the HPV vaccine has touched the public at large. Through social media and highly publicized events, anti-vaccine groups have gained control of the narrative surrounding the HPV vaccine.
Global Collaborators in Action: Trash Honest Scientists to Suppress Inconvenient Evidence
The following case demonstrates how the global network of government/academic and industry stakeholders suppresses information about genuine scientific findings and, when needed, is engaged in corrupt practices to thwart the airing of information about vaccine safety issues.
This case involves inconvenient scientific laboratory findings in post-mortem tissue samples, showing that the HPV vaccine was contaminated with foreign HPV DNA fragments. The case also involves evidence (contained in internal correspondence) of deceptive practices by officials of “authoritative” international public health institutions.
In January 2016, pathologist Dr. Sin Hang Lee, MD, Director of Milford Medical Laboratory, sent an open letter of complaint to the Director-General of the World Health Organization (WHO), Dr. Margaret Chan, in which he challenges the integrity of the GACVS Statement on the Continued Safety of HPV Vaccination (issued March 2014), and charges professional misconduct on the part of the following individuals (and suggests that others may have also been actively involved) in a scheme to deliberately mislead the Japanese Expert Inquiry on human papillomavirus (HPV) vaccine safety before, during and after the February 2014 public hearing in Tokyo.
Dr. Lee challenged the integrity of the GACVS Statement on the Continued Safety of HPV Vaccination written by Dr. Pless, accusing him of deliberately misrepresenting his scientific findings in order to mislead non-scientific readers and those who set vaccination policies.
Dr. Pless is accused of deliberately conflating two unrelated articles, dealing with two different chemicals, written by different authors “apparently to create a target to attack.” Furthermore, Dr. Lee notes that the GACVS Statement relied on an unpublished 12-year-old “Technical Report” written by an unofficial, unnamed “group of participants” (according to CDC’s disclaimer).
These are the facts:
In 2011, Dr. Lee found that every one of the 13 Gardasil samples that he examined contained HPV L1 gene DNA fragments.
He also found that the HPV DNA fragments were not only bound to Merck’s proprietary aluminum adjuvant but also adopted a non-B conformation, thereby creating a new chemical compound of unknown toxicity.
This non-B conformation, Dr. Lee believes, is responsible for the array of autoimmune illnesses experienced by children and young women following vaccination with Gardasil.
In 2012, Dr. Lee testified at a coroner’s inquest of the death of a New Zealand teenager, 6 months after receiving 3 Gardasil vaccine injections.
He then published his case report in the open access journal, Advances in Bioscience and Biotechnology (2012).
Dr. Lee was a presenter at the Tokyo hearing (2014), at which he disputed those who claimed the young women weren’t really suffering severe pain; they were having “psychosomatic reactions.” He stated:
I do not believe psychosomatic reactions can cause sudden unexpected death in sleep, or inflammatory lesions in the brain as demonstrated by the MRI images and the brain biopsy histopathology with perivascular lymphocytes and macrophages and demyelination.
Following the public hearing, GAVC issued a statement (March 12, 2014) aimed at discrediting Dr. Lee’s research by conflating his research with the research of other scientists who presented at the Tokyo hearing.
This case should have been prominently reported in the medical journals and by the mass media, and the allegation should have been investigated.
Mainstream publications have been silent; the case was reported only in alternative news outlets. 
In July 2016, a victims’ group filed a multi-plaintiff lawsuit in the district courts of Tokyo, Nagoya, Osaka, and Fukuoka against the Japanese government and the two pharmaceutical companies that had produced these vaccines.
Furthermore, in December of the same year, additional victims joined the multi-plaintiff lawsuit, bringing the total number of plaintiffs to 119 (Indian Journal of Medical Ethics, 2017).
The Hazards of Aluminum in Vaccines Is the Focus Of Intense Research
Of note: the placebo comparator in (most) vaccine clinical trials is not inert, it contains aluminum.
Several independent teams of international autoimmune experts have investigated this, led by the internationally recognized authority of autoimmune diseases, Dr. Yehuda Shoenfeld of Tel Aviv University, Israel, and another group by Dr. Christopher Exley, Professor of Bioinorganic Chemistry, Keele University in the UK.
However, studies that document the hazards of aluminum in vaccines are not published in major influential medical journals.
Recent surveys of those journals document that medical journal editors have concealed financial conflicts of interest. Most Editors of Top Medical Journals Receive Industry Payments (Retraction Watch, Nov. 2017).
In two cases, journal editors received over $1 million from industry sources. (Ed Silverman, STAT, 2017.)
The following case is an example of how science is subverted by tightly controlled journal gatekeepers. Journal editors who have sold their integrity by accepting industry kickbacks block publication of reports that might pose a financial threat to an intricate web of government and non-government institutions and professional associations – all of whom are financially tied to the pharmaceutical industry.
The case demonstrates the great difficulty encountered by independent scientists who have not sold their integrity to the highest bidder.
Publication Saga: Case Examples of Harassment Aimed At Suppressing Harmful Findings Regarding the HPV-Gardasil Vaccine
The study, Behavioral Abnormalities In Young Female Mice Following Administration Of Aluminum Adjuvants And The Human Papillomavirus (HPV) Vaccine Gardasil, was conducted in Israel by a team of researchers headed by Professor Yehuda Schoenfeld, an internationally recognized authority, who is considered to be the pillar in the field of autoimmunity.
Indeed, Dr. Shoenfeld identified a new syndrome ASIA (Autoimmune/Inflammatory Syndrome Induced by Adjuvants).
The idea of ASIA as a new syndrome developed after some studies on Gulf War syndrome reported that soldiers who had not been deployed to the Gulf area were suffering from symptoms such as severe fatigue, cognitive impairment, myalgias and arthralgias. This raised the question of whether it was the vaccines administered to the soldiers that induced these syndromes. The most common adjuvants are silicone implants and aluminum in vaccines. 
The focus of the research seeks to shed light on “the roles and mechanisms of action of different adjuvants which lead to autoimmune/inflammatory response.”
Prof. Shoenfeld encountered blockades from journal editors who attempted to suppress the findings of neuroinflammation and “behavioral abnormalities following administration of aluminum adjuvants and the HPV vaccine Gardasil.”
Those editors have financial stakes in the business of vaccines.
The HPV-mouse study was first submitted to for publication to the Journal of Human Immunology where it was shelved for 8 months and was then rejected by that journal’s Editor-in-Chief, Dr. Michael Racke.
Dr. Racke has received personal compensation for activities with EMD Serone, Novartis, Roche Diagnostics Corporation, Genentech, and Amarantus as a consultant.
EMD Serono, Inc. is a subsidiary of Merck KGaA, Darmstadt, Germany.
The HPV-mouse study was published in the journal Vaccine in January 2016.
It was summarily withdrawn a month later following orders by the Editor-in-Chief, Gregory Poland. 
Dr. Poland’s direct conflicts of interest  include those disclosed on the Mayo Clinic website:
Dr. Poland is the chairman of a safety evaluation committee for investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative advice on new vaccine development to Merck & Co., Inc. [Dr. Robert Chen is an Associate Editor of Vaccine.]
How is it that this incestuous relationship did not raise loud cries of foul play? Those rejections by editors who had deeply vested financial interest in protecting vaccination rates, whose own financial interest was intertwined with vaccine manufacturers, elicited no protest from the scientific academic community.
Instead, these rejections were followed by vicious attacks against two of the scientists by industry’s cyber hit-squads that are hired to attack independent scientists whose honest research contradicts vaccine orthodoxy. That is viewed as a heresy inasmuch as it poses a financial threat. 
The study was revised, again peer-reviewed, and published in the journal Immunological Research (Nature-Springer) (2017). 
The reported findings remained the same:
Vaccine adjuvants and vaccines may induce autoimmune and inflammatory manifestations in susceptible individuals. To date most human vaccine trials utilize aluminum (Al) adjuvants as placebos despite much evidence showing that Al in vaccine-relevant exposures can be toxic to humans and animals…It appears that Gardasil via its Al adjuvant and HPV antigens has the ability to trigger neuroinflammation and autoimmune reactions, further leading to behavioral changes…
In light of these findings, this study highlights the necessity of proceeding with caution with respect to further mass-immunization practices with a vaccine of yet unproven long-term clinical benefit in cervical cancer prevention.
The basis for those findings was deemed to be scientifically sound by three sets of peer-reviewers, at three different journals.
Note: This article was extracted from Vera Sharav‘s article Betrayal of Public Trust & Institutional Corruption: Vaccine Safety Ratings & Vaccine Science Falsified – which is part of a multi-document series about vaccine fraud and Dr. Andrew Wakefield’s persecution for exposing the truth regarding vaccines.
 Ethical and Legal Challenges of Vaccines and Vaccination Lessons learnt in Japan from adverse reactions to the HPV vaccine: a medical ethics perspective by Hirokuni Beppu, Masumi Minaguchi, Kiyoshi Uchide, Kunihiko Kumamoto, Masato Sekiguchi, Yukari Yaj, Indian Journal of Medical Ethics, 2017
 HPV Vaccination in Japan: The Continuing Debate and Global Impacts, Rose Wilson, Pauline Paterson, Jeremy Chiu, William Schulz, Heidi Larson. A Report of the CSIS Global Health Policy Center, April, 2015
 Scientific/Medical Evidence Presented:
- Dr. Sin Hang Lee – HPV L-1 Gene DNA in Gardasil and Its Potential Effects
- Dr. Jerome Authier – Biopersistance and Neuro migration of Particles after Intramuscular Injection – Impact of long-term safety of aluminum adjuvants
- Lucija Tomljenovic, PhD – Three Deaths Following Human Papillomavirus (HPV) Vaccination: Coincidence?
- Dr. Mirna Hajjar – A 16-Year-Old Girl With Bilateral Visual Loss and Left Hemiparesis Following an Immunization Against Human Papilloma Virus – case report
 Video Q&A: what is ASIA? An interview with Yehuda Shoenfeld, BioMedCentral, 2013
 Detection Of Human Papillomavirus L1 Gene DNA Fragments In Postmortem Blood And Spleen After Gardasil® Vaccination — A Case Report by Sin Hang Lee, Advances in Bioscience and Biotechnology, 2012; WHO: Accusations of Misconduct Over HPV Vaccine Safety Inquiry January 15, 2016 by Thinking Moms’ Revolution
 Behavioral Abnormalities In Young Female Mice Following Administration Of Aluminum Adjuvants And The Human Papillomavirus (HPV) Vaccine Gardasil, RotemInbar Ronen Weiss, LucijaTomljenovic Maria – TeresaArango, JoabChapman, Yehuda Shoenfeld, Vaccine, Jan. 2016; UBC Researcher Defends Gardasil Vaccine Study After It Gets Pulled, Toronto Metro News, 2015; Did Two Medical Journals Just Blacklist Gardasil Research Showing Dangers of the Vaccine? Jefferey Jaxen, Health Impact News, 2016
 As reported by Health Impact News, “Dr. Poland has conducted four studies to date with direct affiliation to Merck. One such study was the pro-HPV trial from 2005, published in Mayo Clinic Proceedings titled Immunogenicity And Reactogenicity Of A Novel Vaccine For Human Papillomavirus 16: A 2-year Randomized Controlled Clinical Trial. Dr. Poland’s 2005 study was published one year before the approval of Gardasil by the FDA in 2006. In addition, Dr. Poland acted as a Safety Monitor for two other clinical trials of HPV vaccines funded by Merck Research Laboratories”. “The Editor-in-Cheif of the Journal of Neuroimmunology, the first journal to withhold and then reject the Gardasil HPV study, is Dr. Michael Racke. According to the American Academy of Neurology: “Dr. Racke has received personal compensation for activities with EMD Serone, Novartis, Roche Diagnostics Corporation, Genentech, and Amarantus as a consultant.” EMD Serono, Inc. is a subsidiary of Merck KGaA, Darmstadt, Germany.”